Pink Chocolate Ice Cream

Made with Ruby Cacao

The ice cream is made to order by Creamistry, in Irvine, U.S. using ultra cold liquid nitrogen that insta-freeze’s the contents of each ice cream.

This flavor is only available for the summer.

Advertisements

What’s for Dinner?

Home-cooked Italay Sicilian-style 4-course Dinner

The Menu

Arancini with white wine and Parmesan

Sicilian pizza

Pasta alla Norma

Whipped ricotta and lemon zest cannoli

Grilled Brie with Pecans

Ingredients

1 tablespoon unsalted butter, softened
1 teaspoon Dijon mustard
1-2 dashes hot pepper sauce
8-inch wheel of brie cheese
1/4 cup chopped pecans
1 teaspoon light brown sugar (optional)

To serve:

toasted French bread
bread sticks
skewered ham cubes
crudites

Method

  1. Preheat grill (broiler).
  2. In a small bowl, combine butter, mustard and hot pepper sauce to taste and spread evenly over top of brie cheese.
  3. Place cheese on a heatproof serving plate or grill (broiler) pan and grill (broil) about 6-inch from heat for 3-4 minutes until top just begins to bubble.
  4. Sprinkle surface of cheese with chopped nuts, and brown sugar, if liked.
  5. Grill (broil) for 2-3 minutes longer until topping is golden and nuts and sugar begin to caramelize and cheese is bubbling.
  6. Remove to a wire rack to cool slightly. If necessary slide on to a warmed serving dish. Serve cheese immediately with accompaniments of your choice.

Makes 10 to 12 servings.

Source: Dips and Salsas

Study: Dark Chocolate Lowers the Risk of Depression

Sarah Knapton wrote . . . . . . . . .

It is food news guaranteed to put a smile on your face. Scientists have found that eating dark chocolate lowers the risk of depression fourfold after eating it.

While 7.6 per cent of the 13,000 people surveyed reported depressive symptoms, just 1.5 per cent of the chocolate eaters did.

The study carried out by University College London (UCL) also found that the people who consumed the most of any chocolate — between 3.6oz (104g) and 16oz (454g) — were also 57 per cent less likely to report depressive symptoms.

Dr. Sarah Jackson, the lead author from UCL’s Institute of Epidemiology and Healthcare, said: “This study provides some evidence that consumption of chocolate, particularly dark chocolate, may be associated with reduced odds of clinically relevant depressive symptoms.

“However, further research is required to clarify the direction of causation. It could be the case that depression causes people to lose their interest in eating chocolate, or there could be other factors that make people both less likely to eat dark chocolate and to be depressed.”

The study is the first to examine the association between depression and the type of chocolate consumed.

British scientists urged caution about the findings, suggesting that, for example, people who ate dark chocolate may be more health conscious in general. Depressed people are also more likely to crave more sugary fatty foods and so could be less likely to pick a dark alternative when choosing chocolate.

Anthony Cleare, professor of psychopharmacology and affective disorders at King’s College London, said: “Although there is an association between lower rates of depression and higher intake of dark chocolate, the main problem with the study is that it cannot tell us whether it is the dark chocolate is protecting against depression or whether it is depression affecting the consumption of dark chocolate.

“We know that depression has marked effects on overall appetite and on the type of foods people crave, and it is just as plausible that the direction of causation is the reverse to the authors’ interpretation.”

“It is also just a snapshot of chocolate consumption over 24 hours, reliant on individuals’ memories, and depression has marked effects on impairing memory. Thus, those with depression may have a less accurate recollection of their intake the day before.”

The research was published in the journal Depression and Anxiety.

Source: National Post

Common Prostate Cancer Treatment May Increase Risk of Fatal Heart Condition

Many men with prostate cancer rely on common testosterone-blocking drugs as a part of their treatment. But those so-called antiandrogens also might put them at risk for a deadly heart condition, according to new research.

In a study published Monday in the American Heart Association journal Circulation, researchers looked at how several testosterone-blocking drugs affect the heart’s QT interval – the time it takes the heart cells to recharge in between beats.

The longer a QT interval, typically measured by an electrocardiogram, the more at risk a person is to develop serious heart rhythm problems and a condition called torsade de pointes, which can result in sudden death. Women naturally have a longer QT interval than men, and they are at higher risk for this form of arrhythmia.

“Testosterone is in part responsible for the protective effect in men,” said lead study author Dr. Joe-Elie Salem, an associate professor of cardiology and pharmacology at Sorbonne University in Paris. “We wanted to see if blocking testosterone with antiandrogens could lead to acute QT prolongation and sudden death.”

Salem and his colleagues used VigiBase, a global health database of reports of suspected adverse effects of medicines filed since 1968. They searched for cases of men with long QT, torsade de pointes or a sudden death associated with testosterone-blocking therapy.

Seven of the 10 drugs they reviewed were disproportionally associated with either long QT, torsade de pointes or sudden death. The drug enzalutamide, which is used to treat metastatic prostate cancer, was linked with more deaths than any other antiandrogen.

The impact and interaction of drugs on the heart’s rhythms “is an important issue that probably doesn’t get as much attention as it deserves in terms of drug safety,” said Dr. Richard J. Kovacs, Q.E. and Sally Russell Professor of Cardiology at the Indiana University School of Medicine. “When we actively search for cases of drug-induced torsade, such as this research team did, we find that the incidence of the problem is often orders of magnitude greater than what’s discovered by just passive surveillance.”

Salem said more research should explore the interaction between antiandrogens and other drugs and conditions that also can also prolong QT. For example, electrolyte disorders caused by low potassium can impact the heart’s rhythm.

“When you’re giving antiandrogen drugs, you should probably monitor for torsade de pointes and be very careful about controlling the other risk factors for QT prolongation,” Salem said.

Kovacs, who was not involved in the new study, recommended that before prescribing medication to patients who take antiandrogen drugs, doctors check CredibleMeds.org. The organization tracks medications that have a known or potential risk of QT prolongation.

The list includes dozens of drugs, including commonly prescribed antibiotics such as ciprofloxacin and antidepressants such as citalopram, known by its brand name, Celexa.

“If you have a patient who is taking an antiandrogen,” Kovacs said, “and you have a choice of prescribing an antibiotic that increases torsade de pointes risk and one that doesn’t, wouldn’t you choose the one that doesn’t?”

Kovacs suggested that oncologists and cardiologist work together to manage QT prolongation and the risk of torsade de pointes in high-risk prostate cancer patients.

“There are off-target effects, and they can be life-threatening,” he said. “How do you mitigate the risk? I think that’s the most important follow-up question.”

Source: HealthDay


Today’s Comic